Correlation Between Scpharmaceuticals and Prothena Plc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Prothena Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Prothena Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Prothena plc, you can compare the effects of market volatilities on Scpharmaceuticals and Prothena Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Prothena Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Prothena Plc.

Diversification Opportunities for Scpharmaceuticals and Prothena Plc

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Scpharmaceuticals and Prothena is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Prothena plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prothena plc and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Prothena Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prothena plc has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Prothena Plc go up and down completely randomly.

Pair Corralation between Scpharmaceuticals and Prothena Plc

Given the investment horizon of 90 days Scpharmaceuticals is expected to generate 0.99 times more return on investment than Prothena Plc. However, Scpharmaceuticals is 1.01 times less risky than Prothena Plc. It trades about -0.14 of its potential returns per unit of risk. Prothena plc is currently generating about -0.2 per unit of risk. If you would invest  391.00  in Scpharmaceuticals on September 14, 2024 and sell it today you would lose (60.00) from holding Scpharmaceuticals or give up 15.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Scpharmaceuticals  vs.  Prothena plc

 Performance 
       Timeline  
Scpharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Prothena plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prothena plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Scpharmaceuticals and Prothena Plc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scpharmaceuticals and Prothena Plc

The main advantage of trading using opposite Scpharmaceuticals and Prothena Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Prothena Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prothena Plc will offset losses from the drop in Prothena Plc's long position.
The idea behind Scpharmaceuticals and Prothena plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Valuation
Check real value of public entities based on technical and fundamental data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance